Mizuho Securities Starts Rapid7 (RPD) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts RPD Hot Sheet
Rating Summary:
10 Buy, 19 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 17 | Down: 28 | New: 13
Join SI Premium – FREE
Mizuho Securities analyst Gregg Moskowitz initiates coverage on Rapid7 (NASDAQ: RPD) with a Buy rating and a price target of $59.00.
The analyst comments "RPD's relatively new cloud-based Insight platform has fueled an acceleration in ARR growth, and we expect the company will continue growing at a healthy rate in CY19-20. Despite a large 85% gain in the shares over the past 12 months, RPD still trades at a reasonable 6x CY20E revenue multiple for a company expected to grow ARR >30%."
For an analyst ratings summary and ratings history on Rapid7 click here. For more ratings news on Rapid7 click here.
Shares of Rapid7 closed at $50.37 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Assumes MiNK Therapeutics (INKT) at Buy
- CVS Health (CVS) PT Lowered to $103 at Jefferies
- Datadog (DDOG) PT Lowered to $245 at Stifel
Create E-mail Alert Related Categories
Analyst Comments, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
